Clinical Trials Browser

OTHER × Depression × Escitalopram × Clear all

NCT00667121 2025-02-14

Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline

Breast Neoplasms, Depression, Hot Flashes

NCT00536172 2023-09-21

PROTECT

Phase 4 Completed

160 enrolled 15 charts

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT00352885 2018-09-14

Effectiveness of Escitalopram in Preventing or Reducing Depressive Symptoms in People Receiving Interleukin-2 Treatment

Phase 4 Completed

20 enrolled 11 charts

Depression, Neoplasms

NCT00621946 2014-02-04

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Phase 4 Completed

26 enrolled 13 charts

Asthma, Depression, Depressive Disorder, Major, Lymphoma, Follicular

NCT00387348 2012-12-03

Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer

Phase 3 Terminated

24 enrolled 11 charts

GastrointestinalThoracic

Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Depression, Esophageal Neoplasms, Fatigue, Gallbladder Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms